A Nasdaq-listed technology company in the US is planning to buy a large amount of a surprise altcoin.
Digital ophthalmic technology company Eyenovia announced that it has signed a $50 million private equity investment (PIPE) agreement with institutional investors.
With this funding, the company plans to create a cryptocurrency reserve by purchasing HYPE, the native token of the Hyperliquid blockchain, and change the company’s name to “Hyperion DeFi.” Its new ticker symbol will be “HYPD.”
Eyenovia has also appointed Hyunsu Jung as Chief Investment Officer (CIO) and Board Member to lead its crypto treasury strategy.
According to the company’s press release, the $50 million investment will offer investors non-voting preferred stock, convertible into approximately 15.4 million shares at $3.25 per share, and approximately 30.8 million shares of stock at the same price (warrant). If the warrants are fully exercised, Eyenovia’s total gross revenue could reach $150 million.
“We are pleased to be among the companies that have adopted this strategy to evaluate the diversification, liquidity and long-term capital appreciation potential of cryptocurrencies. After examining all alternatives, we have determined that this step is in the best interest of our shareholders,” said CEO Michael Rowe.
“I am honored to lead this pioneering crypto treasury strategy built around HYPE. We believe Hyperliquid is one of the fastest growing and most revenue-generating blockchains in the world,” said Jung, new Chief Investment Officer.
With this agreement, Eyenovia aims to become one of the most active validators on the Hyperliquid network globally by purchasing over 1 million HYPE tokens. In addition, a staking program will be launched in collaboration with Anchorage Digital.
